About Lassen Therapeutics
Lassen Therapeutics is developing novel, best-in-class biotherapeutics to improve the lives of patients suffering from serious diseases.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
San Diego, United States
Year Founded
2018
Team Size
11-50
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
lassentherapeutics.com
Domain Registered Date
Oct 19, 2018
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $85,000,000 · Series-B+
fundraisingfox.com
- Capital Raise
Raised $31,000,000 · Series-A
- Milestone
Website domain registered
lassentherapeutics.com
- Milestone
Company founded
San Diego, United States
Investors & Backers
Alta Partners
Biotechnology Value Fund
Catalio
Frazier Healthcare Partners
Frazier Life Sciences
Longitude Capital
Longwood Capital Partners
Longwood Fund
Funding History
Series-B+
· Jan 17, 2024
$85,000,000 fundraisingfox.com
Series-A
· Jun 17, 2020
$31,000,000 Source
Founders & Leadership
David King
Co-Founder & CSO
Work email & phone locked
Unlock →
H. Toni Jun
VP, Preclinical Development
Work email & phone locked
Unlock →
Maria Fardis
Chief Executive Officer
Work email & phone locked
Unlock →
Mark Barrett
Founder
Work email & phone locked
Unlock →
Robert Horlick
Vice President, Molecular Cell Biology
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026